Catalyst Pharmaceuticals, Inc.

NasdaqCM:CPRX Stock Report

Market Cap: US$1.9b

Catalyst Pharmaceuticals Management

Management criteria checks 3/4

Catalyst Pharmaceuticals' CEO is Rich Daly, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.18% of the company’s shares, worth $3.34M. The average tenure of the management team and the board of directors is 3.8 years and 11.2 years respectively.

Key information

Rich Daly

Chief executive officer

US$390.2k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.2%
Management average tenure3.8yrs
Board average tenure11.2yrs

Recent management updates

Recent updates

Earnings Tell The Story For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Jan 29
Earnings Tell The Story For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Catalyst Pharmaceuticals: Until The TEVA ANDA Is Resolved, There Is A Risk

Jan 17

With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case

Sep 06
With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case

Should You Be Adding Catalyst Pharmaceuticals (NASDAQ:CPRX) To Your Watchlist Today?

May 27
Should You Be Adding Catalyst Pharmaceuticals (NASDAQ:CPRX) To Your Watchlist Today?

Do Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings Warrant Your Attention?

Feb 13
Do Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings Warrant Your Attention?

Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?

Nov 11
Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?

Catalyst Pharmaceuticals gains 9% on SmallCap 600 addition

Sep 12

Catalyst Pharma ends momentum as Roth downgrades

Aug 24

Catalyst Pharmaceuticals: Performing Above Expectations

Aug 12

Catalyst: Upside Outlier - In Search Of A Catalyst

May 11

Catalyst: A Classic Case Of Watch That Basket

Jan 20

CEO

Rich Daly (62 yo)

less than a year

Tenure

US$390,177

Compensation

Mr. Richard John Daly, also known as Rich, MBA, had been an Independent Director at Catalyst Pharmaceuticals, Inc. from February 2015 until January 1, 2024 and serves as its Chief Executive Officer and Dir...


Leadership Team

NamePositionTenureCompensationOwnership
Patrick McEnany
Co-Founder & Chairman22.2yrsUS$6.92m3.84%
$ 71.3m
Richard John Daly
Presidentless than a yearUS$390.18k0.18%
$ 3.3m
Steven Miller
Executive VP14.4yrsUS$3.47m0.70%
$ 13.0m
Gary Ingenito
Chief Medical & Regulatory Officer8.8yrsUS$2.48m0.044%
$ 809.4k
Jeffrey Del Carmen
Executive VP & Chief Commercial Officer3.8yrsUS$2.39m0.022%
$ 409.0k
Michael Kalb
Executive VP & CFOless than a yearno datano data
Mary Coleman
VP & Head of Investor Relations2.6yrsno datano data
Brian Elsbernd
Chief Compliance Officer & Chief Legal Officer8.1yrsUS$353.27k0.13%
$ 2.4m
Pete Curry
Vice President of Sales3.8yrsno datano data
Stanley Iyadurai
Senior Vice President of Medical Affairs & Drug Discoveryless than a yearno datano data
Preethi Sundaram
Chief Strategy Officer2.7yrsUS$1.70m0.022%
$ 402.3k
Philip Schwartz
Corporate Secretaryno datano datano data

3.8yrs

Average Tenure

61yo

Average Age

Experienced Management: CPRX's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Patrick McEnany
Co-Founder & Chairman22.2yrsUS$6.92m3.84%
$ 71.3m
Richard John Daly
President9.1yrsUS$390.18k0.18%
$ 3.3m
David Tierney
Independent Director21.4yrsUS$398.05k0.30%
$ 5.5m
Donald Denkhaus
Independent Director9.1yrsUS$403.30k0.37%
$ 6.9m
Charles O'Keeffe
Lead Independent Director19.3yrsUS$425.68k0.58%
$ 10.8m
Eugene Laska
Member of Scientific Advisory Boardno datano datano data
Robert Fechtner
Member of Scientific Advisory Boardno datano datano data
Jonathan Brodie
Chairman of Scientific Advisory Boardno datano datano data
Molly Harper
Independent Director2.8yrsUS$390.18k0.0045%
$ 83.9k
Richard Silverman
Member of Scientific Advisory Board13.3yrsno datano data
Tamar Thompson
Independent Directorless than a yearno datano data

11.2yrs

Average Tenure

62yo

Average Age

Experienced Board: CPRX's board of directors are seasoned and experienced ( 11.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.